The identification of human carcinogens and primary prevention of cancer

Mutation Research - Reviews in Mutation Research

Volumn 462, Issue 2-3, 2000, Pages 407-421

  Tomatis, Lorenzo ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Human carcinogens; Prevention; Target organs

Indexed keywords

AFLATOXIN; ANTHRACENE DERIVATIVE; AROMATIC AMINE; ARSENIC; ASBESTOS; ASPHALT; AURAMINE; AZATHIOPRINE; BENZIDINE; CARCINOGEN; CHEMICAL AGENT; CHROMIUM; COKE; CREOSOTE; DIESEL FUEL; DRUG; INDUSTRIAL CHEMICAL; LEAD; LIQUID PARAFFIN; MELPHALAN; MUSTARD GAS; RADON; SEMUSTINE; THIOTEPA; TOBACCO SMOKE; UNINDEXED DRUG; URANIUM; VINYL CHLORIDE;

CANCER; CANCER PREVENTION; HUMAN; IONIZING RADIATION; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; SMOKELESS TOBACCO; TARGET ORGAN; TOBACCO;

ANIMALIA;

EID: 0034124963     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(00)00029-6     Document Type: Article

References (48)

1. J. Hill, Cautions Against the Immoderate Use of Snuff, Baldwin, Jackson, London 1761 (Quoted in: M.B. Shimkin, Contrary to Nature, DHEW Publication no. (NIH) 79-720, Washington, DC, 1979.
2. J. Hill, Cautions Against the Immoderate Use of Snuff, Baldwin, Jackson, London 1761 (Quoted in: M.B. Shimkin, Contrary to Nature, DHEW Publication no. (NIH) 79-720, Washington, DC, 1979.
3. P. Pott, Chirurgical Observations Relative to the Cataract, the Polypus of the Nose, the Cancer of the Scrotum, the Different Kinds of Ruptures and the Mortifications of Toes and Feet, Hawes, Clarke, Collins, London, 1775.
4. Hutchinson J. On some examples of arsenic keratosis of the skin and of arsenic cancer. Trans. Pathol. Soc. London. 39:1888;352-363.
5. Rehn L. Bladder tumours in Fuchsin workers. Arch. Klin. Chirugie. 50:1895;588-600.
6. W.C. Roentgen, Ueber eine neue Art von Strahlen, Sitzungsber, Phys. Med. Gesellsch. Wurtzb., (1895) 132-141 (Quoted in: Shimkin, M.B., op.cit.).
7. W.C. Roentgen, Ueber eine neue Art von Strahlen, Sitzungsber, Phys. Med. Gesellsch. Wurtzb., (1895) 132-141 (Quoted in: Shimkin, M.B., op.cit.).
8. Frieben A. Demonstration eines Cancroid der rechten Handruckens da sich nach langdauernder Einwirkung von Roetgnen strahlen entwickelt hat. Fortschr. Roentgenstr. 6:1902;106-111.
9. Sick H. Karzinom der Haut das auf den Boden eines Roetgenulcus entstanden ist. Muench. Med. Wochenschr. 50:1902;1445.
10. Schuttmann W. Schneeberg lung disease and uranium mining in the Saxon ore mountain (Erzgebirge). Am. J. Ind. Med. 23:1993;355-368.
11. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans, Vol. 43, Man-made Mineral Fibers and Radon, IARC, Lyon, 1988.
12. IARC Monographs on the Evaluation of the Carcinogenic Risk to Humans, Vol. 38, Tobacco Smoking, IARC, Lyon, 1986.
13. International Labour Office (ILO), Cancer of the bladder among workers in aniline factories, In: Studies and Reports, series F No.1, ILO, Geneva, Switzerland, 1921.
14. Tomatis L. The predictive value of rodent carcinogenicity tests in the evaluation of human risk. Annu. Rev. Pharmacol. Toxicol. 19:1979;511-530.
15. Montesano R., Tomatis L. Legislation concerning chemical carcinogens in several industrialized countries. Cancer Res. 37:1977;310-316.
16. Carnevale F., Montesano R., Partensky C., Tomatis L. Comparison of regulations on occupational carcinogens in several industrialized countries. Am. J. Ind. Med. 12:1987;453-473.
17. Wynder E.L., A Graham F. Tobacco smoking as a possible etiologic factor in bronhiogenic carcinoma. A study of six hundred and eighty-four proved cases. J. Am. Med. Ass. 143:1950;329-336.
18. Doll R., Hill R.A. Smoking and carcinoma of the lung. Br. Med. J. 2:1950;739-748.
19. M.P. Coleman, J. Esteve, P. Damiecki, A. Arslan, H. Renard (Eds.), Trends in Cancer Incidence and Mortality, IARC Scientific Publication 121, IARC, Lyon, 1993.
20. Wingo P.A., Ries L.A., Giovino G.A., Miller D.S., Rosenberg H.M., Shpland D.R., Thun M.J., Edwards B.K. Annual report to the nation on the status of cancer 1973-1996, with a special section on lung cancer and tobacco smoking. J. Natl. Cancer Inst. 91:1999;675-690.
21. Peto R., Lopez A.D., Boreham J., Thun M., Heath C., Doll R. Mortality from smoking worldwide. Br. Med. Bull. 52:1996;12-21.
22. W.C. Hueper, W.D Conway, Chemical Carcinogenesis and Cancers, Charles C. Thomas, Springfield, IL, 1964.
23. World Health Organization, Prevention of Cancer, Technical Report Series 276, WHO, Geneva, 1964.
24. IARC Monographs on the Evaluation of the Carcinogenic Risk to Humans, Vols. 1-71, IARC, Lyon, 1972-1999.
25. H. Vainio, P.N. Magee, D.B. McGregor, A.J. McMicheael (Eds.), Mechanisms of Carcinogenesis in Risk Identification, IARC Scientific Publication 116, IARC, Lyon 1992.
26. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 54, Occupational Exposures to Mists and Vapours from Strong Inorganic Acids and Other Industrial Chemicals, IARC, Lyon, 1993.
27. Environmental Protection Agency (EPA) Proposes guidelines fro carcinogenbic risk assessment, notice of availability and opportunity to comment on proposed guidelines fro carcinogen risk assessment. Fed. Reg. 61:1996;17959-18011.
28. C.C. Capen, E. Dybing, J.M. Rice, J.D. Wilbourn, (Eds.), Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis, IARC Scientific Publication 147, IARC, Lyon, 1999.
29. Melnick R.L., Kohn M.C., Huff J. Weight of evidence versus weight of speculation to evaluate the alpha 2u-globulin hypothesis. Environ. Health Perspect. 105:1997;904-906.
30. Huff J.E. NTP report on carcinogens: history, concepts, procedures, processes. Eur. J. Oncol. 3:1998;343-355.
31. National Toxicology Program, Eighth Report on Carcinogens, US Dept. of Health and Human Services, Public Health Service, NTP, Research Triangle Park, NC, 1998.
32. Haddow A. Proceedings of the Ninth International Cancer Congress, Tokyo, 1966, UICC Monograph Series. 9:1967;111-116.
33. Boyland E. The correlation of experimental carcinogenesis and cancer in man. Progr. Exp. Tumor Res. 11:1969;222-234.
34. Wynder E.L., Gori G.B. Contribution of the environment to cancer incidence: an epidemiological exercise. J. Natl. Cancer Inst. 58:1977;825-832.
35. Higginson J., Muir C.S. Environmental carcinogenesis: misconceptions and limitations to cancer control. J. Natl. Cancer Inst. 63:1979;365-384.
36. Doll R., Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst. 66:1981;1191-1308.
37. L. Tomatis, A. Aitio, N.E. Day, E. Heseltine, J. Kaldor, A. Miller, D.M. Parkin, E. Riboli (Eds.), Cancer Causes, Occurrence and Control, IARC Scientific Publication 100, Lyon, France, 1990.
38. Tomatis L., Huff J., Hertz-Picciotto I., Sandler D.P., Bucher J., Boffetta P., Axelson O., Blair A., Taylor J., Stayner L., Barrett J.C. Avoided and avoidable risks of cancer. Carcinogenesis. 18:1997;97-105.
39. N. Pearce, E. Matos, H. Vainio, P. Boffetta, M. Kogevinas (Eds.), Occupational Cancer in Developing Countries, IARC Scientific Publication 129, IARC, Lyon, 1994.
40. Castleman B.L. The migration of industrial hazards. Int. J. Occup. Environ. Health. 1:1995;85-96.
41. S. Roe, Deadly Alliance, The Blade, March 28-April 2, Toledo, OH, 1999.
42. Merler E., Vineis P., Alhaique P., Miligi L. Occupational cancer in Italy. Environ. Heallth Perspect. 107:1999;259-271.
43. Dunnick J.K., Elwell M.R., Huff J., Barrett J.C. Chemically induced mammary gland cancer in the National Toxicology Program's carcinogenesis bioassay. Carcinogenesis. 16:1995;173-179.
44. A. Bradford Hill, Principles of Medical Statistics, The Lancet, London, 1971.
45. K.J. Rothman, Modern Epidemiology, Little, Brown and Co., Boston, 1986.
46. Stayner L. Protecting public health in the face of uncertain risk: the example of diesel exhaust. Am. J. Public Health. 89:1999;991-993.
47. Hayes R.B., Yin S.N., Dosemeci M., Li G.L., Wacholder S., Travis L.B., Li C.Y., Rothman N., Hoover R.N., Linet M.S. Benzene and the dose-related incidence of hematologic neoplasms in China. J. Natl. Cancer Inst. 89:1997;1065-1071.
48. Huff J. Chemicals and cancer in humans: first evidence in experimental animals. Environ. Health Perspect. 100:1993;201-210.